Related Experiment Video
Updated: Jul 17, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Factor VIII and the risk of arterial thrombosis]
Rafał Małecki1, Rajmund Adamiec
1Klinika Angiologii, Nadciśnienia Tetniczego i Diabetologii Akademii Medycznej we Wrocławiu. rmalecki@gazeta.pl
Abstract:
The pathomechanism of acute complications of atheromatosis, i.e. arterial thrombosis, still remains unclear. Conventional cardiovascular risk factors can explain only about 50% of cases of arterial thrombosis. The activation of intrinsic and extrinsic pathways of the coagulation system on damaged atherosclerotic plaque is one of the most important mechanisms. The role of clotting factors in the development of arterial thrombosis is also considered. From among a few clotting factors (V, VIII, XIII), factor VIII arouses interest due to the well-known observation that the morbidity for cardiovascular reasons is less among hemophiliacs than in the general population. A high factor VIII level predicts the occurrence of episodes of venous thromboses, but its role in the pathogenesis of arterial thromboses is still unclear. In clinical studies, a high factor VIII level predicts episodes of stroke, myocardial infarct, and acute lower-limb ischemia over a short period of observation. A high factor VIII level may the cause of about 5% of all episodes of arterial thrombosis. The reasons for elevated factor VIII levels in some persons remain unclear. Although heritability can play an important role, the influence of other factors (e.g. activation of the sympathetic nervous system) has been reported. The pathomechanism is the subject of investigation as well. An explanation for the occurrence of severe complications of arterial thrombosis in patients without significant risk factors may result in the development of methods of detection and prevention.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
